DelveInsight’s “Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Alcoholic Hepatitis, historical and forecasted epidemiology as well as the Alcoholic Hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Alcoholic Hepatitis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Alcoholic Hepatitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Alcoholic Hepatitis Market Insights
Alcoholic Hepatitis Overview
Alcoholic hepatitis (AH), as the name suggests, is hepatitis – inflammation of the liver – due to excessive intake of alcohol. Patients typically have a history of heavy alcohol intake, about 8–10 drinks per day. It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to fibrosis progression, leading to cirrhosis.
Some of the key facts of the Alcoholic Hepatitis Market Report:
- The Alcoholic Hepatitis market size was valued at USD 5.0 Million in the year 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
- The diagnosed moderate-to-severe alcoholic hepatitis cases in the 7MM countries were 657,524 in 2020
- The United States had the highest prevalent alcoholic hepatitis population, with 146,159 cases in 2020
- Key Alcoholic Hepatitis Companies: Durect Corporation, Novartis, Akaza Bioscience, and others
- Key Alcoholic Hepatitis Therapies: DUR-928, Canakinumab, TAK-242, and others
- The Alcoholic Hepatitis epidemiology based on gender analyzed that there are more cases for Alcoholic Hepatitis in males than females
Get a Free sample for the Alcoholic Hepatitis Market Report-
https://www.delveinsight.com/sample-request/alcoholic-hepatitis-market
Key benefits of the Alcoholic Hepatitis Market report:
- Alcoholic Hepatitis market report covers a descriptive overview and comprehensive insight of the Alcoholic Hepatitis Epidemiology and Alcoholic Hepatitis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Alcoholic Hepatitis market report provides insights on the current and emerging therapies.
- Alcoholic Hepatitis market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Alcoholic Hepatitis market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Alcoholic Hepatitis market.
Download the report to understand which factors are driving Alcoholic Hepatitis epidemiology trends @ Alcoholic Hepatitis Epidemiological Insights
Alcoholic Hepatitis Market
The dynamics of the Alcoholic Hepatitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
“Diagnosing AH can be challenging as the disease has widely varying presentations and, in severe cases, can mimic a bacterial infection and/or biliary obstruction. Some major key players in the market are Durect Corporation and Novartis.”
Alcoholic Hepatitis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Alcoholic Hepatitis Epidemiology Segmentation:
The Alcoholic Hepatitis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalence of Alcoholic Hepatitis
- Prevalent Cases of Alcoholic Hepatitis by severity
- Gender-specific Prevalence of Alcoholic Hepatitis
- Diagnosed Cases of Episodic and Chronic Alcoholic Hepatitis
Alcoholic Hepatitis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Alcoholic Hepatitis market or expected to get launched during the study period. The analysis covers Alcoholic Hepatitis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Alcoholic Hepatitis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Discover more about therapies set to grab major Alcoholic Hepatitis market share @ Alcoholic Hepatitis market forecast
Alcoholic Hepatitis Therapies and Key Companies
- DUR-928: Durect Corporation
- Canakinumab: Novartis
- TAK-242: Akaza Bioscience
Alcoholic Hepatitis Market Drivers
- Emerging Alcoholic Hepatitis Therapies
- Novel Treatment Options
- Large Patient Pool
- Technological Advances
Scope of the Alcoholic Hepatitis Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Alcoholic Hepatitis Companies: Durect Corporation, Novartis, Akaza Bioscience, and others
- Key Alcoholic Hepatitis Therapies: DUR-928, Canakinumab, TAK-242, and others
- Alcoholic Hepatitis Therapeutic Assessment: Alcoholic Hepatitis current marketed and Alcoholic Hepatitis emerging therapies
- Alcoholic Hepatitis Market Dynamics: Alcoholic Hepatitis market drivers and Alcoholic Hepatitis market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Alcoholic Hepatitis Unmet Needs, KOL’s views, Analyst’s views, Alcoholic Hepatitis Market Access and Reimbursement
Alcoholic Hepatitis Market Barriers
- Mortality
- High Cost of Alcoholic Hepatitis Treatment
- Key Barriers to Drug Development
Table of Contents
1. Alcoholic Hepatitis Market Report Introduction
2. Executive Summary for Alcoholic Hepatitis
3. SWOT analysis of Alcoholic Hepatitis
4. Alcoholic Hepatitis Patient Share (%) Overview at a Glance
5. Alcoholic Hepatitis Market Overview at a Glance
6. Alcoholic Hepatitis Disease Background and Overview
7. Alcoholic Hepatitis Epidemiology and Patient Population
8. Country-Specific Patient Population of Alcoholic Hepatitis
9. Alcoholic Hepatitis Current Treatment and Medical Practices
10. Alcoholic Hepatitis Unmet Needs
11. Alcoholic Hepatitis Emerging Therapies
12. Alcoholic Hepatitis Market Outlook
13. Country-Wise Alcoholic Hepatitis Market Analysis (2019–2032)
14. Alcoholic Hepatitis Market Access and Reimbursement of Therapies
15. Alcoholic Hepatitis Market Drivers
16. Alcoholic Hepatitis Market Barriers
17. Alcoholic Hepatitis Appendix
18. Alcoholic Hepatitis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To know more about Alcoholic Hepatitis treatment, visit @ Alcoholic Hepatitis Medications
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting